Trial Profile

Safety, Tolerability, and Pharmacokinetics of Proxalutamide Therapy in Women With Metastatic Breast Cancer: an Open-label, Multi-center, Dose-escalatingPhase I/Ib Study.

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 17 Oct 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

28 Sep 2022 Results (n=45) published in the European Journal of Cancer
28 Sep 2022 According to a Kintor Pharmaceutical media release, Professor Huiping Li of Peking University Cancer Hospital & Institute, was the principal investigator of this study.
28 Sep 2022 According to a Kintor Pharmaceutical media release, data from this study have been published in published in the international journal, European Journal of Cancer (2021 Impact Factor: 10.002, EJC).

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com